iSpecimen Inc. Files 8-K: Regulation FD Disclosure & Exhibits

TL;DR

iSpecimen filed an 8-K for Reg FD disclosure and exhibits. Details TBD.

AI Summary

On September 4, 2025, iSpecimen Inc. filed a Form 8-K to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits at this time.

Why It Matters

This filing indicates that iSpecimen Inc. is providing important updates or disclosures to the public, which could affect investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.

Key Players & Entities

• iSpecimen Inc. (company) — Registrant
• September 4, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-40501 (identifier) — SEC File Number
• 27-0480143 (identifier) — IRS Employer Identification No.
• 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Principal executive offices
• (781) 301-6700 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share ISPC The Nasdaq Stock Mar
• $200 million — ess model, by seeking to build an up to $200 million corporate treasury reserve based on the

Filing Documents

• ea0256078-8k_ispecimen.htm (8-K) — 25KB
• ea025607801ex99-1_ispecimen.htm (EX-99.1) — 9KB
• 0001213900-25-084497.txt ( ) — 201KB
• ispc-20250904.xsd (EX-101.SCH) — 3KB
• ispc-20250904_lab.xml (EX-101.LAB) — 33KB
• ispc-20250904_pre.xml (EX-101.PRE) — 22KB
• ea0256078-8k_ispecimen_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 4, 2025, iSpecimen Inc. (the "Company") issued a press release announcing an update on its strategic initiative aimed at integrating digital assets into its business model. The Company had previously announced that it is pursuing a strategic initiative aimed at integrating digital assets into its business model, by seeking to build an up to $200 million corporate treasury reserve based on the Solana blockchain ecosystem. Since announcing its intentions in August 2025, the Company has been approached by several Crypto currency-related companies that have presented opportunities in tokenized real-world assets as well as among highly ranked cryptocurrencies. In a parallel path, the Company has continued meetings to build a Solana-based treasury program. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in this Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated September 4, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 4, 2025 iSPECIMEN INC. By: /s/ Robert Bradley Lim Name: Robert Bradley Lim Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR